BackEntasis Therapeutics Holdings Overview

Entasis Therapeutics Holdings Total Assets

Track Entasis Therapeutics Holdings's total assets ($44M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$44.09M
↓ 16.54% YoYΔ $-8.73M vs prior year quarter

Peer trimmed avg / median

Loading

Entasis Therapeutics Holdings Total Assets History

Loading

Entasis Therapeutics Holdings vs. peers: Total Assets Comparison

Loading

Entasis Therapeutics Holdings Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Entasis Therapeutics Holdings (ETTX) FAQ

As of the most recent data (March 2022), ETTX shows a total assets of $44M. That compares with $53M in the prior-year period — down 16.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ETTX's total assets is now $44M (was $53M) — a 16.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Entasis Therapeutics Holdings is outperforming or lagging.

Tracking ETTX's total assets over time shows whether Entasis Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $44M That compares with $53M in the prior-year period — down 16.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Entasis Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $44M) with ownership activity and broader fundamentals.

Entasis Therapeutics Holdings's total assets is $44M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.